Keyphrases
Colorectal Cancer
100%
Prospective Audit
78%
Lymph Node Ratio
71%
Colon Cancer
65%
National Cohort Study
64%
Left-handed
47%
Colorectal Resection
47%
Anastomotic Leak
44%
Colon Resection
37%
Neoadjuvant Therapy
35%
Postoperative Complications
34%
Right-sided
33%
Colon Surgery
31%
Intracorporeal Anastomosis
31%
Robotic Right Colectomy
31%
Treatment Results
31%
Tumour Subsite
31%
Intracorporeal
31%
Complication Rate
30%
Major Complications
20%
Primary Anastomosis
20%
Tumor Stage
19%
Colorectal Surgery
18%
Leakage Rate
17%
Improved Survival
17%
Lymph Node
17%
Surgeons
17%
Operative Approach
17%
Postoperative Mortality
17%
Randomized Clinical Trial
16%
Triple-blind
16%
Right Hemicolectomy
16%
Inflammatory Biomarkers
15%
Subcutaneous Adipose Tissue
15%
Plasma Vitamin D
15%
Inflammation
15%
Age-dependent
15%
Surgery Effect
15%
Abdominal Obesity
15%
Postoperative Survival
15%
Stapling Technique
15%
Operative
15%
Transanal Total Mesorectal Excision (taTME)
15%
Right Colectomy
15%
Anastomotic Failure
15%
Pathological Complete Response
15%
Pathological Response
15%
Specialism
15%
National Cohort
15%
Prognostic Value
15%
Medicine and Dentistry
Colectomy
73%
Surgery
64%
Surgical Anastomosis
62%
Rectum Cancer
55%
Colon Cancer
47%
Anastomosis Leakage
44%
Postoperative Complication
37%
Cancer Surgery
34%
Colorectal Cancer
32%
Extracorporeal
31%
Surgeon
19%
Stoma
17%
Surgical Mortality
17%
Hemicolectomy
17%
Randomized Clinical Trial
16%
Coloproctology
15%
Randomized Controlled Trial
15%
Vitamin D
15%
Lymph Node
15%
Total Mesorectal Excision
15%
Adipose Tissue
15%
Patient with Crohn's Disease
15%
Colon Surgery
15%
Pembrolizumab
15%
DNA Mismatch Repair
15%
Abdominal Obesity
15%
Open Surgery
15%
Malignant Neoplasm
15%
Intestine Preparation
15%
Antibiotics
15%
Chemoradiotherapy
15%
Postoperative Recovery
10%
Mortality Rate
8%
Crohn's Disease
7%
Biological Marker
7%
Laparoscopy
7%
Laparoscopic Surgery
7%
Logistic Regression Analysis
6%
Rectum Resection
6%
Multivariate Analysis
5%
Tumor Cell
5%
Indocyanine Green
5%
Immune Checkpoint Inhibitor
5%
Neoplasm
5%
Case Mix
5%
